Scottish biotech secures £2.3 million investment

Biotangents has secured £2.3m in a funding round led by Eos and British Business Investments, alongside existing investors Kelvin Capital and Scottish Enterprise and will commence on-farm trials across the UK and internationally later next year.

Based on the Pentland Science Park in Midlothian Science Zone, the innovative animal health diagnostics company claims to be developing the world’s fastest on-farm, point-of-care diagnostic device for addressing disease in dairy cows.